7.5mg Mounjaro Not Working: What to Do Next

You've been on 7.5mg for a few weeks and the number on the scales hasn't moved

Here's the scene: you titrated up from 5mg, felt the familiar appetite suppression in the first week or two, and then... progress levelled off. The meals are smaller, but the loss has slowed or stopped. It feels like the medicine has stopped working. In most cases, it hasn't.

Tirzepatide works by activating two gut-hormone receptors involved in appetite regulation and blood-sugar control, slowing how quickly food leaves the stomach and reducing the drive to eat. The NHS patient information page on tirzepatide explains this mechanism clearly. What that page also notes is that the licensed schedule runs from 2.5mg all the way to 15mg (seven steps) and most people are nowhere near their optimal dose at 7.5mg. SURMOUNT-1, the pivotal phase-3 trial, found average body-weight reductions of around 20–21% at the 15mg maintenance dose over 72 weeks. At mid-range doses the effect is real but not yet maximal.

One misconception worth letting go gently: that hitting a plateau means your body is "resistant" to the medicine. Tolerance to tirzepatide in that sense has not been a feature of the clinical trial data. What the trials do show is a dose-response relationship, more of the medicine, within the licensed range, generally produces more weight loss. Your body adapting to a given dose is normal physiology, not a sign that the medicine is worn out.

If 7.5mg mounjaro is not working as hoped, the conversation to have is with your prescriber, not a search engine. They can look at the full picture before deciding what comes next. You can explore how tirzepatide works across the full treatment journey to understand what each stage is designed to do.

What your prescriber will actually consider before changing anything

A prescriber reviewing 7.5mg Mounjaro not working will look at several things before recommending a dose increase or any other change.

How long you've been at 7.5mg. The licensed titration schedule moves in roughly four-week steps, but that's a minimum, not a hard deadline. Some people benefit from staying at a dose longer before moving up, especially if side effects were significant on the way there. A few weeks of slower loss doesn't automatically mean the dose needs to change.

Whether appetite suppression has faded. If the medicine felt clearly effective for the first two weeks and then less so, that's a recognisable pattern and usually responds well to moving to 10mg. If it never felt particularly effective, that's a different conversation, worth raising honestly with your prescriber.

If you've had similar questions at an earlier dose, the experience of 5mg Mounjaro feeling ineffective follows a similar pattern, and many of the same principles apply here.

Lifestyle factors that reduce the medicine's effect. Tirzepatide is licensed alongside a reduced-calorie diet and increased activity, this isn't small print. Periods of poor sleep, high stress, alcohol, or a return to previous eating patterns can all attenuate the appetite-suppressing effect that makes the medicine work. Your prescriber may ask about these specifically, not to judge, but because addressing them alongside any dose change produces better outcomes.

How weight loss is being measured. Weight fluctuates by several pounds over a week from fluid shifts, sodium intake, and hormonal changes. Prescribers tend to look at trend over 4–6 weeks rather than any single weigh-in. What looks like a plateau on any given morning may be masking genuine progress.

What typically happens between 7.5mg and the higher doses

The licensed doses above 7.5mg are 10mg, 12.5mg and 15mg. For many people, the jump from 7.5mg to 10mg is when the medicine begins to feel meaningfully more effective. NICE's appraisal of tirzepatide (TA1026) reviewed the SURMOUNT trial programme (including data across multiple dose levels) and found the clinical evidence compelling enough to recommend tirzepatide as the first GLP-1 class medicine approved at this scale through NICE. The appraisal notes that the evidence base supports the full licensed dose range.

If you are finding that even an earlier dose such as 2.5mg felt like it wasn't doing enough, it is worth understanding that this starting dose is designed to build tolerance rather than drive significant loss, so the same principles of patience and supervised titration apply throughout the journey. Treatment begins with the Mounjaro Quick Pen at 2.5mg, a format many people find straightforward to use from the very first injection.

If 7.5mg mounjaro is not working as well as expected and four or more weeks have passed at this dose without meaningful progress, the case for a supervised increase to 10mg is usually strong. Your prescriber will also look at whether you're still experiencing any side effects, since moving up too quickly when GI symptoms are present can make those worse. Pages covering what to expect if 10mg also underperforms and the 12.5mg experience address similar questions at each subsequent step.

The cost of treatment as it moves through doses is a practical question for many people. If that's on your mind, the weight-loss treatment overview sets out what's included in a private prescription at each stage, which is worth reading before your next clinical review. For anyone ready to have that conversation now, you can start your free consultation with our prescribers, every review at dose-increase stage is completed by a real clinician the same day it's submitted.